Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab (PDS) End of Study Results

Related

• 

  AMD Neovascular Expert Panel

  Robert L. Avery, MD

  Nizar S Abdelfattah, M.D.

  Nancy M. Holekamp, MD, FASRS

  Peter K. Kaiser, MD FASRS

  Pravin U. Dugel, MD

  Annual Meeting Talks

  2016

• 

  Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv

  Raj K. Maturi, MD

  Updates from the Field

  2017

• 

  Episode 24: Acute Retinal Angiographic Changes with Intravitreal Injections with Dr. Richard Rosen

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2019